Alfa Aesar has announced the addition of a variety of cancer research tools to its expanding range of bio products.
Cancers result from the accumulation of abnormalities (mutations) in the cell’s genetic material.
These mutations can be due to a number of reasons including exposure to carcinogens, ionizing radiation, viral infection, errors in deoxyribonucleic acid (DNA) replication, or inherited defects.
Mutations resulting in cancer frequently occur in oncogenes (genes that cause normal cells to become cancerous tumor cells) or in tumor suppressor genes.
Alfa Aesar’s cancer research product range offers numerous reagents, including those that have known anti-tumor or cancer preventive properties and a short list of carcinogens.